“a nonsignificant trend”

Early tigecycline start demonstrated a nonsignificant trend toward lower mortality (OR 0.64; 95% CI, 0.40–1.03; p = 0.066), but no other covariates approached the predefined threshold for inclusion based solely on univariate significance.

Red Blood Cell Counts Blood cell counts in patients were not significantly different from those of the control groups, with the single exception of a nonsignificant trend for MCHC, slightly lower in the autistic group (* P ≥ 0.0669) ( Table 1 ).

A reduced logistic regression with only vitamin B12 and ferritin (EPV=7.5) found that vitamin B12 remained significantly associated with psychosocial impairment (OR=0.983; 95% CI: 0.971-0.995; P=0.006), while ferritin showed a nonsignificant trend (OR=0.972; 95% CI: 0.943-1.002; P=0.067).

We also detected a nonsignificant trend ( P = 0.067) towards more orange coloration in the larger‐brained males.

20 Nonetheless, even in this ‘less-obese’ cohort, there is a significant, stepwise, association between severity of ED and obesity, when evaluated with WC measurement ( r = 0.166, P = 0.001, Figure 1a ); whereas, for BMI, only a nonsignificant trend was observed ( r = 0.09, P = 0.067, Figure 1b ).

Immune cell number changes were assessed by immunofluorescence staining ( Figure 1 C), which revealed significant reductions in CD3 + T cells ( P = .025), CD4 + cells ( P = .002), and CD3 + CD4 − (CD8) T cells ( P = .02), and a nonsignificant trend for decreases in CD3 + CD4 + T cells ( P = .067) and CD3 − CD4 + cells ( P = .055; Figure 1 D).

This domain showed a nonsignificant trend ( P = 0.067) when comparing the IBP Lower vs.

For White children, the RBC DHA was weakly, but positively, associated with scores on the PPVT (rho = 0.211, P = 0.008) and the KABC Sequential (rho = 0.182, P = 0.022) scale, with a nonsignificant trend for the MPI scale (rho = 0.149, P = 0.067, n = 152) ( Table 5 ).

There was a nonsignificant trend for hospitalisations (IRR = 1.556, p = .067, 95 %CIs: 0.97, 2.50).

47 There was a nonsignificant trend towards a greater percentage of nonoperative vs operative patients who completed the full 30 minutes of treadmill walk testing: 80% vs 68% ( P = .067), respectively. 47 Articles with Decision-Making Algorithms or Criteria for Operative vs Nonoperative Treatment Study results demonstrated 6 articles on decision-making algorithms or criteria for operative vs nonoperative ASD treatment, which are summarized in Table 5 .

For OS, higher CD8 + TIL density showed a nonsignificant trend toward benefit in the surgery‐only subgroup (HR = 0.37, 95% CI: 0.13–1.07, p = 0.067).

The normo-increasing group exhibited a nonsignificant trend toward lower ESKD incidence relative to the high-decreasing group (HR = 0.49, SE = 0.19, P = 0.067).

There was a nonsignificant trend to a reduced duration of antibiotic therapy among LRTI studies ( p = 0.067), which showed significant heterogeneity between trials.

The difference between female and male leg length approached significance, with females exhibiting a nonsignificant trend towards longer legs ( t (37) = 1.89, p = 0.067).

Relationships Between Questionnaire Outcome Measures and HR Measures There was a nonsignificant trend for a relationship between total METs per week engaged in yoga, and HF-HRV during the EE condition ( r = 0.43, p = 0.067; Figure 4 ).

On univariate analysis, PCOM was significantly associated with better recurrence-free survival (RFS) (P=0.009), and BMI ≥25 kg/m 2 exhibited a nonsignificant trend for longer RFS (P=0.0674).

A nonsignificant trend was observed with IRF ( p =0.0676; Figure 3 ). 3.3.

In the HR cohort, patients treated with Gla-300 showed a nonsignificant trend toward lower nocturnal hypoglycemia compared with those treated with Gla-100 (EDITION 2, 25.3% vs. 38.0%, P = 0.0678; EDITION 3, 24.2% vs. 32.7%, P = 0.1903) ( Table 3 ).

In the high-risk cohort, patients treated with Glar-300 showed a nonsignificant trend toward lower nocturnal hypoglycemia compared with those treated with Glar-100 [25.3% versus 38.0% ( P = 0.0678) for the EDITION 2 trial and 24.2% versus 32.7% ( P = 0.1903) for the EDITION 3 trial].

Additionally, a nonsignificant trend was identified between levodopa prescription and reduced 3-month mortality (adjusted hazard ratio = 0.67, p = 0.068).

Functional improvement was also observed in subscales of SDS; the SDS-social life subscore ( P = 0.003) and the SDS-family life/home responsibilities subscore (P = 0.003) were improved significantly when compared with the placebo group, and there was a nonsignificant trend towards improvement on the SDS-work/school subscore ( P = 0.068).

SSV treatment showed a nonsignificant trend toward higher odds (odds ratio, 2.12; 95% CI, 0.95-4.76; P = .068).

Although there was a nonsignificant trend toward patients with lymph node-only disease receiving LRT in higher proportion (37% vs. 21.5%; P = .068), no differences were observed in patients with visceral (22.7% vs. 26.7%; P = .725) or bone-only (28.7% vs. 20.5%; P = .125) metastases.

Furthermore, although the incidence of bronchiolitis was similar across subtypes, both bronchitis and laryngotracheobronchitis exhibited a nonsignificant trend toward a higher proportion being diagnosed in the RSV-A group ( P = 0.068 and P = 0.066, respectively).

When analyzing the evolution of malnutrition risk according to the degree of adherence to the digital nutritional program, patients with a higher percentage of adherence showed greater MUST score improvement at 24 weeks compared with those with lower adherence ( p = 0.045), while at 12 weeks a nonsignificant trend was observed ( p = 0.068).